Adult T-Cell Lymphoma/Leukemia (DBCOND0124654)
Identifiers
- Synonyms
- Adult T-Cell Leukemia-Lymphoma / Adult T-cell lymphoma/leukaemia / ATLL / Adult T-cell lymphomas/leukaemias / Adult T-cell lymphoma/leukemia / Adult T-cell lymphoma/leukemia (HTLV-1-associated) / Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission / Adult T-cell leukemia/lymphoma (morphologic abnormality) / Adult T-cell leukemia/lymphoma (disorder) / Adult T-cell lymphoma/leukaemia NOS / Leukemia-Lymphoma, Adult T-Cell / T-lymphoblastic leukemia (disorder) / T-cell lymphoblastic leukemia acute / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / T-lymphoblastic leukemia (morphologic abnormality) / T-cell type acute leukemia / T-cell type acute leukaemia / T-cell lymphoblastic leukaemia acute
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT01676805 Tissue Collection for Studies of Lymph Cancer No drug interventions Not Available Not Available recruiting NCT02682667 Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols No drug interventions Not Available Not Available recruiting NCT00920790 Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphoma treatment 2 completed NCT01626664 KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) treatment 2 completed NCT01169298 A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma treatment 1 completed NCT02737046 Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma treatment 2 active_not_recruiting NCT01173887 Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 treatment 2 completed NCT01724177 A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma treatment 2 completed NCT01000285 EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma treatment 1 / 2 completed NCT00699296 Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma treatment 2 terminated NCT04185220 Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome treatment 1 completed NCT04008394 Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies No drug interventions treatment 1 unknown_status NCT04014374 Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab No drug interventions Not Available Not Available recruiting